Clinical Efficacy of Osimertinib in Patients with Advanced Non-Small Cell Lung Cancer and Its Effect on Serum CEA and VEGF Expression

OBJECTIVE: To assess the clinical efficacy of osimertinib in patients with advanced non-small cell lung cancer and its effect on serum carcinoembryonic antigen (CEA) and vascular endothelial growth factor (VEGF) expression. METHODS: Between July 2018 and January 2020, 80 patients with advanced non-s...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Huanyuan, Zhou, Xiangwu, Wang, Zhaozhen, Lu, Tianzhu, Li, Baoliang, Jiang, Sicong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9159882/
https://www.ncbi.nlm.nih.gov/pubmed/35664943
http://dx.doi.org/10.1155/2022/3032087

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9159882/
https://www.ncbi.nlm.nih.gov/pubmed/35664943
http://dx.doi.org/10.1155/2022/3032087

Ejemplares similares